NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome
Authors
Keywords
-
Journal
Cells
Volume 10, Issue 8, Pages 2034
Publisher
MDPI AG
Online
2021-08-09
DOI
10.3390/cells10082034
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?
- (2021) Marta Flisiak-Jackiewicz et al. Journal of Clinical Medicine
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC
- (2021) Dominik Pfister et al. NATURE
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma
- (2020) Tatsuo Kanda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Updated efficacy and safety of KEYNOTE-224: A phase II study of pembrolizumab (pembro) in patients with advanced hepatocellular carcinoma (HCC).
- (2020) Masatoshi Kudo et al. JOURNAL OF CLINICAL ONCOLOGY
- Epidemiology of Hepatocellular Carcinoma
- (2020) Katherine A. McGlynn et al. HEPATOLOGY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Feasibility of a Very Low Calorie Diet to Achieve a Sustainable 10% Weight Loss in Patients With Nonalcoholic Fatty Liver Disease
- (2020) Jadine Scragg et al. Clinical and Translational Gastroenterology
- Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
- (2020) Daniel Q. Huang et al. Nature Reviews Gastroenterology & Hepatology
- Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2019) A Vogel et al. ANNALS OF ONCOLOGY
- Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes
- (2019) Fabio Nascimbeni et al. ATHEROSCLEROSIS
- Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts
- (2019) Myriam Alexander et al. BMC Medicine
- Hepatocellular Carcinoma
- (2019) Augusto Villanueva NEW ENGLAND JOURNAL OF MEDICINE
- Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
- (2019) Gordon I. Smith et al. JOURNAL OF CLINICAL INVESTIGATION
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Evolution of NAFLD and Its Management
- (2019) Manpreet S. Mundi et al. NUTRITION IN CLINICAL PRACTICE
- Lipotoxicity and the gut-liver axis in NASH pathogenesis
- (2018) Fabio Marra et al. JOURNAL OF HEPATOLOGY
- Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial
- (2018) Richard S. Finn et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
- (2018) Noura S. Abul-Husn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases
- (2018) Jonathan G. Stine et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Lean non-alcoholic fatty liver disease
- (2018) Alice Yuxin Wang et al. CLINICAL NUTRITION
- Serum leptin and leptin resistance correlations with NAFLD in patients with type 2 diabetes
- (2018) Simona Cernea et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
- (2018) Fasiha Kanwal et al. GASTROENTEROLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
- (2016) Sahil Mittal et al. Clinical Gastroenterology and Hepatology
- The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent
- (2016) Rosellina Margherita Mancina et al. GASTROENTEROLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Global Epidemiology of Hepatocellular Carcinoma
- (2015) Katherine A. McGlynn et al. Clinics in Liver Disease
- Nonalcoholic Fatty Liver Disease, Diabetes, Obesity, and Hepatocellular Carcinoma
- (2015) Mazen Noureddin et al. Clinics in Liver Disease
- Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study
- (2015) Rohit Loomba et al. GASTROENTEROLOGY
- Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
- (2015) Zobair M. Younossi et al. HEPATOLOGY
- The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment
- (2015) Cristina Margini et al. LIVER INTERNATIONAL
- Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma
- (2015) Hamza Chettouh et al. LIVER INTERNATIONAL
- Leptin in nonalcoholic fatty liver disease: A narrative review
- (2015) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysis
- (2014) Amit G Singal et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma
- (2014) Y.-L. Liu et al. JOURNAL OF HEPATOLOGY
- Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
- (2014) Julia Kozlitina et al. NATURE GENETICS
- Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease
- (2014) Xue-Qun Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- Radiologic evaluation of nonalcoholic fatty liver disease
- (2014) Seung Soo Lee WORLD JOURNAL OF GASTROENTEROLOGY
- Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
- (2013) Howard C. Masuoka et al. Annals of the New York Academy of Sciences
- Clinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinoma
- (2013) Sang Soo Lee et al. BMC CANCER
- The burden of liver disease in Europe: A review of available epidemiological data
- (2013) Martin Blachier et al. JOURNAL OF HEPATOLOGY
- Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
- (2013) Shin Yoshimoto et al. NATURE
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
- (2012) Dianne H. Dapito et al. CANCER CELL
- Potential for statins in the chemoprevention and management of hepatocellular carcinoma
- (2012) Amedeo Lonardo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Role of ceramides in nonalcoholic fatty liver disease
- (2012) Mangesh Pagadala et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease
- (2011) Lars P. Bechmann et al. HEPATOLOGY
- Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey
- (2011) Katsutoshi Tokushige et al. JOURNAL OF GASTROENTEROLOGY
- Obesity, inflammation, and liver cancer
- (2011) Beicheng Sun et al. JOURNAL OF HEPATOLOGY
- Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease
- (2010) P. Dongiovanni et al. GUT
- Fatty liver incidence and predictive variables
- (2010) Akira Tsuneto et al. HYPERTENSION RESEARCH
- Role of Insulin Resistance and Lipotoxicity in Non-Alcoholic Steatohepatitis
- (2009) Kenneth Cusi Clinics in Liver Disease
- Genetic polymorphisms in non-alcoholic fatty liver disease:Clues to pathogenesis and disease progression
- (2009) Marko Duvnjak et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH
- (2008) Giovanni Musso et al. HEPATOLOGY
- Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice
- (2008) Catherine Postic et al. JOURNAL OF CLINICAL INVESTIGATION
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
- (2008) Jean-Philippe Coppé et al. PLOS BIOLOGY
- Nonalcoholic Fatty Liver Disease: Pathogenesis and Potential for Nuclear Receptors as Therapeutic Targets
- (2007) Jacob George et al. MOLECULAR PHARMACEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started